The association of arsenic exposure and metabolism with type 1 and type 2 diabetes in youth: The search case-control study

Diabetes Care

Volumn 40, Issue 1, 2017, Pages 46-53

  Grau Pérez, Maria ^a,b   Kuo, Chin Chi ^a,c,d   Spratlen, Miranda ^a   Thayer, Kristina A ^e   Mendez, Michelle A ^f   Hamman, Richard F ^g   Dabelea, Dana ^g   Adgate, John L ^g   Knowler, William C ^h   Bell, Ronny A ⁱ   Miller, Frederick W ^e   Liese, Angela D ^j   Zhang, Chongben ^f   Douillet, Christelle ^f   Drobná, Zuzana ^f,k   Mayer Davis, Elizabeth J ^f,l   Styblo, Miroslav ^f   Navas Acien, Ana ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Medicine   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f University of North Carolina   (United States)

^g Food Science and Human Nutrition   (United States)

^h NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF SOUTH CAROLINA   (United States)

^k NORTH CAROLINA STATE UNIVERSITY   (United States)

^l UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; CYANOCOBALAMIN; DIMETHYLATED ARSENIC; FOLIC ACID; INORGANIC ARSENIC; MONOMETHYLATED ARSENIC; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CARBON METABOLISM; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; VITAMIN BLOOD LEVEL; ANALYSIS; BLOOD; ENVIRONMENTAL EXPOSURE; YOUNG ADULT;

ADOLESCENT; ARSENIC; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID; HUMANS; MALE; VITAMIN B 12; YOUNG ADULT;

EID: 85008196499     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0810     Document Type: Article

References (38)

1. Kuo CC, Moon K, Thayer KA, Navas-Acien A. Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep 2013;13:831-849
2. European Food Safety Authority. Scientific opinion on arsenic in food: Panel on Contaminants in the Food Chain. EFSA J 2009;7:1351. Available from http://www.efsa.europa.eu/en/scdocs/scdoc/1351.htm.Accessed 12December 2011
3. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008;300: 814-822
4. Maull EA, Ahsan H, Edwards J, et al. Evaluation of the association between arsenic and diabetes: A National Toxicology Programworkshop review. Environ Health Perspect 2012;120:1658-1670
5. Dangleben NL, Skibola CF, Smith MT. Arsenic immunotoxicity: A review. Environ Health 2013; 12:73
6. Lu K, Abo RP, Schlieper KA, et al. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect 2014;122:284-291
7. Douillet C, Currier J, Saunders J, Bodnar WM, Matoušek T, Stýblo M. Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. Toxicol Appl Pharmacol 2013;267:11-15
8. National Research Council. Arsenic in Drinking Water. Washington, DC, National Academies Press, 1999
9. Kuo CC, Howard BV, Umans JG, et al. Arsenic exposure, arsenic metabolism, and incident diabetes in the Strong Heart Study. Diabetes Care 2015;38:620-627
10. Currier JM, Ishida MC, González-Horta C, et al. Associations between arsenic species in exfoliated urothelial cells and prevalence of diabetes among residents of Chihuahua, Mexico. Environ Health Perspect 2014;122:1088-1094
11. Mendez MA, Gonzalez-Horta C, Sánchez-Ramírez B, et al. Chronic exposure to arsenic and markers of cardiometabolic risk: A crosssectional study in Chihuahua, Mexico. Environ Health Perspect 2016;124:104-111
12. Dabelea D,Mayer-Davis EJ, Lamichhane AP, et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: The SEARCH Case-Control Study. Diabetes Care 2008;31:1422-1426
13. Gamble MV, Liu X, Ahsan H, et al. Folate and arsenic metabolism: A double-blind, placebocontrolled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 2006;84:1093-1101
14. Peters BA, Hall MN, Liu X, et al. Folic acid and creatine as therapeutic approaches to lower blood arsenic: A randomized controlled trial. Environ Health Perspect 2015;123:1294-1301
15. Finer S, Saravanan P, Hitman G, Yajnik C. The role of the one-carbon cycle in the developmental origins of type 2 diabetes and obesity. Diabet Med 2014;31:263-272
16. Hamman RF, Bell RA, Dabelea D, et al.; SEARCH for Diabetes in Youth Study Group. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care 2014;37:3336-3344
17. Dabelea D, Pihoker C, Talton JW, et al.; SEARCH for Diabetes in Youth Study. Etiological approach to characterization of diabetes type: The SEARCH for Diabetes in Youth Study. Diabetes Care 2011;34:1628-1633
18. Liese AD, Puett RC, Lamichhane AP, et al. Neighborhood level risk factors for type 1 diabetes in youth: The SEARCH Case-Control Study. Int J Health Geogr 2012;11:1
19. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-444
20. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000 (314):1-27
21. Tamura T. Determination of food folate. J Nutr Biochem 1998;9:285-293
22. Matoušek T, Currier JM, Troj ánková N, et al. Selective hydride generation-cryotrapping-ICP-MS for arsenic speciation analysis at picogram levels: analysis of river and sea water reference materials and human bladder epithelial cells. J Anal At Spectrom2013;28:1456-1465
23. R Core Team. R: A language and environment for statistical computing [Internet], 2014. Vienna, Austria, R Foundation for Statistical Computing. Available from http://R-project.org. Accessed 27 October 2016
24. Babyak MA. Rescaling continuous predictors in regressionmodels [article online]. PsychosomMed 24 September 2009. Available from http://stattips .blogspot.com/2009/08/rescaling-continuouspredictors-in.html. Accessed 27 October 2016
25. Ryker SJ. Mapping arsenic in ground water [article online]. Geotimes 2001;46:34-36. Available from http://water.usgs.gov/nawqa/trace/pubs/geo-v46n11/fig2.html. Accessed 27 October 2016
26. Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D, Punshon T, Karagas MR. Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect 2012;120: 1418-1424
27. Laine JE, Bailey KA, Rubio-Andrade M, et al. Maternal arsenic exposure, arsenic methylation efficiency, and birth outcomes in the Biomarkers of Exposure to ARsenic (BEAR) pregnancy cohort in Mexico. Environ Health Perspect 2015;123: 186-192
28. Rager JE, Yosim A, Fry RC. Prenatal exposure to arsenic and cadmium impacts infectious disease-related genes within the glucocorticoid receptor signal transduction pathway. Int J Mol Sci 2014;15:22374-22391
29. Tolins M, Ruchirawat M, Landrigan P. The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure. Ann Glob Health 2014;80:303-314
30. Tseng CH, Tai TY, Chong CK, et al. Long-term arsenic exposure and incidence of non-insulindependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000;108:847-851
31. Maull EA, Ahsan H, Edwards J, et al. Evaluation of the association between arsenic and diabetes: A National Toxicology Program workshop review. Environ Health Perspect 2012;120: 1658-1670
32. KimNH,Mason CC, Nelson RG, et al. Arsenic exposure and incidence of type 2 diabetes in southwestern American Indians. AmJ Epidemiol 2013;177:962-969
33. James KA, Marshall JA, Hokanson JE, Meliker JR, Zerbe GO, Byers TE. A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus. Environ Res 2013;123:33-38
34. Melak D, Ferreccio C, Kalman D, et al. Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile. Toxicol Appl Pharmacol 2014;274:225-231
35. Chen Y, Wu F, Liu M, et al. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect 2013; 121:832-838
36. Nizam S, Kato M, Yatsuya H, et al. Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh. Int J Environ Res Public Health 2013;10:1006-1019
37. Walton FS, Harmon AW, Paul DS, Drobná Z, Patel YM, Styblo M. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol 2004;198:424-433
38. Peters BA, Hall MN, Liu X, et al. Renal function is associated with indicators of arsenicmethylation capacity in Bangladeshi adults. Environ Res 2015; 143:123-130